Pratap Chand Mali | Zoology | Outstanding Scientist Award

Published on by Cell Biologist

Prof. Pratap Chand Mali | Zoology | Outstanding Scientist Award

Prof. Pratap Chand Mali | University of Rajasthan Jaipur | India

Dr. Pratap Chand Mali  is a seasoned Professor in the Department of Zoology at the University of Rajasthan, Jaipur. With over three decades of research experience in reproductive physiology, his scientific work centers on the antifertility effects of traditional medicinal plants. Known for his meticulous approach and ethical experimentation, Dr. Mali has contributed significantly to contraceptive research using animal models, particularly male albino rats. His pioneering studies explore plant-based alternatives to synthetic contraceptives, showcasing his deep interest in eco-friendly and indigenous healthcare solutions. Dr. Mali has actively participated in national and international scientific platforms, delivering invited talks and contributing to numerous peer-reviewed journals. A member of esteemed organizations like the Indian Science Congress Association and ISSRF, his academic and research journey reflects a commitment to innovation and excellence in biological sciences.

Publication Profile: 

Google Scholar

Orcid

Education:

Dr. Pratap Chand Mali holds an M.Sc. and a Ph.D. in Zoology from the University of Rajasthan. His doctoral thesis, titled “Antifertility Studies of Certain Xerophytic Plants in Male Albino Rats”, focused on exploring the contraceptive potential of native plant extracts on male reproductive systems. His specialization in reproductive biology and physiology has equipped him with a strong foundation in experimental design, pharmacological testing, and histopathological analysis. His research is notable for blending traditional botanical knowledge with modern pharmacology, aiming to develop safe, natural contraceptive agents. Throughout his academic career, Dr. Mali has demonstrated a keen interest in understanding plant bioactives and their systemic effects. He has trained several postgraduate and doctoral students and remains an inspiration in his field due to his in-depth academic training and practical experience.

Experience:

Dr. Pratap Chand Mali serves as a Professor in the Department of Zoology at the University of Rajasthan, with extensive teaching and research experience spanning over 30 years. His academic involvement includes undergraduate and postgraduate teaching, student mentorship, and curriculum development. He has supervised several Ph.D. scholars and has actively contributed to departmental research initiatives, particularly in reproductive toxicology and phytopharmacology. His research has been widely presented in national symposia and international conferences, including an invited speaker session in Dubai in 2021. Dr. Mali has been instrumental in bridging traditional plant medicine with reproductive physiology, establishing himself as a leading voice in antifertility research. His collaborative projects with Indian and international scientists reflect a global recognition of his expertise. His teaching philosophy emphasizes scientific curiosity and ethical research, making him a respected academic leader in his institution and the broader scientific community.

Awards and Honors:

Dr. Mali’s work has earned him several prestigious honors. He received the Asia-Pacific Council on Contraception (APCOC) Talents Encouragement Award in 2008 for his poster on the contraceptive activity of Withania somnifera at a conference held in Macau, China. In 2010, he was honored with the Best Citizen of India Award, acknowledging his contributions to science and education. He was also an Invited Speaker at the Pharmacology 2021 international conference in Dubai, where he delivered a lecture on traditional medicinal plants in modern pharmacopeia. A Life Member of the Indian Science Congress Association and the Indian Society for the Study of Reproduction and Fertility (ISSRF), his consistent academic contributions are highly valued. These awards and affiliations reflect his dedication to advancing knowledge in reproductive biology and his impactful role in both national and international scientific communities.

Research Focus:

Dr. Pratap Chand Mali’s research centers on the antifertility potential of traditional medicinal plants, particularly in male reproductive physiology. His experimental work involves phytochemical screening, hormonal analysis, and histological studies using male albino rats to assess the impact of various xerophytic plant extracts. His aim is to develop natural, reversible, and safe contraceptives by leveraging indigenous botanical knowledge. Dr. Mali’s investigations into plants such as Martynia annua, Euphorbia neriifolia, and Citrullus colocynthis have significantly contributed to understanding non-toxic alternatives to synthetic reproductive inhibitors. He is also interested in the mechanisms of spermatogenesis inhibition, lipid metabolism, and endocrine disruption by phytocompounds. His work is published in reputed journals like Journal of Ethnopharmacology and Pharmaceutical Biology, with several papers receiving international citations. Through his interdisciplinary research, he continues to address global fertility challenges using eco-conscious solutions grounded in Indian traditional medicine.

Publications Top Notes:

  1. Antifertility studies of root extract of Martynia annua Linn in male albino rats – Indian Science Congress, 1994

  2. Inhibition of spermatogenesis by Euphorbia neriifolia extract in male rats – ISSRF Symposium, 1994

  3. Antifertility study of Citrullus colocynthis fruit extract in male rats – ISSRF, 1994

  4. Antifertility effects of Echinops echinatus roots in male rats – J. Environ and Pollu., 1995

  5. Fertility regulation using Echinops echinatus root extract in rats – J. Phytol. Res., 1995

  6. Hypolipidemic effect of Convolvulus microphyllus in cholesterol-fed gerbils – J. Phytol. Res., 1995

  7. Antispermatogenic activity of Solanum xanthocarpum root extract in rats – J. Phytol. Res., 1996

  8. Antifertility effects of Euphorbia neriifolia root in male albino rats – Indian J. Environ. Sci., 1999

  9. Antispermatogenic effect of Citrullus colocynthis root extract – Pharmaceutical Biology, 2001

  10.  Effects of Martynia annua root extract on male rats – J. Ethnopharm., 2002

Conclusion:

Dr. Pratap Chand Mali is a deserving candidate for the Research for Outstanding Scientist Award based on the originality, depth, and societal relevance of his work. His pioneering studies on plant-based male contraceptives not only address a critical public health need but also contribute to sustainable and accessible healthcare innovation. His combination of academic leadership, consistent publication record, and international recognition through awards and invited talks makes him a valuable asset to the scientific community. With further strategic efforts to amplify his research’s reach and impact, he is well-positioned to continue making meaningful contributions to science and society. The award would serve as a well-earned recognition of his lifelong dedication to scientific inquiry and translational research in reproductive physiology.

 

 

 

John Carethers | DNA Repair | Best Researcher Award

Published on by Cell Biologist

Prof. John Carethers | DNA Repair | Best Researcher Award

Prof. John Carethers, UC San Diego, United States

Dr. John M. Carethers is a distinguished academic leader and physician-scientist in the field of gastroenterology and cancer genetics. Serving as Vice Chancellor for Health Sciences at the University of California San Diego, he also holds professorial appointments in both the School of Medicine and the Herbert Wertheim School of Public Health. His extensive contributions to colorectal cancer research, health disparities, and tumor biology have earned him national recognition. Dr. Carethers is renowned for his work on DNA mismatch repair mechanisms and their implications in cancer progression and treatment responsiveness. With a prolific publication record and influential roles in medicine and science policy, he stands as a model for translational research excellence. His commitment to mentorship and health equity further underscores his holistic impact on the field of medicine. Dr. Carethers continues to push scientific boundaries while advocating for inclusive healthcare solutions.

Publication Profile: 

Google Scholar

Scopus

Education:

Dr. Carethers completed his undergraduate education at Wayne State University, earning a B.S. in Biological Sciences with a minor in Chemistry (1981–1985). He graduated with distinction and was a recipient of the Michigan State Competitive Scholarship. He continued at Wayne State University School of Medicine, where he earned his M.D. with High Distinction in 1989. His academic performance was recognized with multiple honors including the Dean’s Academic Achievement Award and awards from the Black Medical Association. Dr. Carethers then completed an internship in Internal Medicine at Massachusetts General Hospital (1989–1990), a prestigious Harvard-affiliated institution, under the guidance of Chief of Medicine Dr. John T. Potts. His medical and research training provided the foundation for a career focused on gastrointestinal disorders, tumor genetics, and health disparities, particularly in colorectal cancer. His formative years reflect academic excellence and an early commitment to advancing medicine through both practice and research.

Professional Experience:

Dr. John M. Carethers currently serves as the Vice Chancellor for Health Sciences at the University of California San Diego. He is also a Distinguished Professor in the Department of Medicine and an Adjunct Professor in the School of Public Health. His career has spanned prestigious academic roles, including clinical and research leadership in gastroenterology, particularly focused on colorectal cancer. A physician-scientist, Dr. Carethers has served in roles that bridge bench science and clinical application, contributing significantly to translational medicine. His academic journey includes mentorship of emerging scientists, leadership in national research initiatives, and board participation in scientific organizations. His experience also encompasses major roles in cancer health disparities research, aiming to close gaps in outcomes across racial and socioeconomic lines. Dr. Carethers is a prolific researcher and thought leader whose experience enhances institutional vision, diversity, and health equity. His impactful career exemplifies a dedication to excellence in science and medicine.

Awards and Honors:

Dr. Carethers has been recognized with numerous academic and professional honors throughout his career. As an undergraduate, he received the Michigan State Competitive Scholarship and was inducted into the Golden Key National Honor Society. During medical school, he earned the Dean’s Academic Achievement Award and awards from the Black Medical Association in 1986 and 1987. Over time, he has been widely honored for his contributions to colorectal cancer research, healthcare leadership, and advocacy for health equity. His published work has been highly cited and influential in advancing our understanding of tumor genetics and mismatch repair. He has received numerous invitations for keynote talks and appointments to national research boards and committees. Dr. Carethers’s career has been marked by his commitment to mentoring, scholarly productivity, and advocacy, positioning him as a leader and role model in academic medicine. These honors underscore his national and global influence in health sciences.

Research Focus:

Dr. John M. Carethers’s research primarily focuses on colorectal cancer, particularly mechanisms of tumor progression, genetic and epigenetic alterations, and mismatch repair (MMR) deficiency. He has deeply explored how MMR status influences treatment responses, especially to chemotherapy agents like 5-fluorouracil. A key aspect of his work includes identifying biomarkers for cancer prognosis and understanding familial cancer syndromes, including Lynch syndrome and polyposis syndromes. His studies also delve into the molecular mechanisms underlying microsatellite instability (MSI) and its role in genomic instability. Importantly, Dr. Carethers is a leading voice in cancer health disparities, examining how social, economic, and biological factors impact outcomes among underrepresented populations. His research bridges basic molecular science with clinical applications, enabling personalized approaches to treatment and surveillance. Through his work, he contributes to reducing cancer burden and mortality while promoting health equity in vulnerable communities—making him a pioneer in both biomedical research and public health.

Publications Top Notes:

  1.  Experimental and clinical observations on frostbite

  2.  The epidemiology of methicillin-resistant Staphylococcus aureus in a burn center

  3.  Extraintestinal Manifestations of Crohn’s Disease

  4.  Human chromosome 3 corrects mismatch repair deficiency in colon tumor cells

  5.  Delayed gastric emptying after laparoscopic vagotomy

  6.  Mismatch repair and the G2 cell cycle checkpoint

  7. In vitro assay for screening hMLH1 and hMSH2 mutations

  8.  Massive secretory diarrhea and pseudo-obstruction in Crohn’s disease

  9.  Mismatch repair blocks clonal expansion after DNA damage

  10.  Localization of Bannayan-Riley-Ruvalcaba syndrome gene to chromosome 10q23

Conclusion:

In conclusion, Dr. John M. Carethers embodies the highest standards of research excellence, leadership, and societal impact. His contributions to colorectal cancer genetics, DNA mismatch repair research, and cancer health disparities are not only scientifically rigorous but also clinically transformative. As a widely respected physician-scientist, educator, and health equity advocate, he represents the ideal blend of scholarly productivity and service to humanity. Despite minor opportunities for expanding the global and technological dimensions of his work, Dr. Carethers’s achievements place him in the top tier of biomedical researchers. His continued dedication to both advancing science and closing health outcome gaps aligns perfectly with the spirit of the Best Researcher Award. He is not only deserving of this honor but also serves as an inspiring model for current and future generations of researchers.

Dukagjin Blakaj | Radiation Oncology | Best Researcher Award

Published on by Cell Biologist

Prof. Dukagjin Blakaj | Radiation Oncology | Best Researcher Award

Prof. Dukagjin Blakaj, The Ohio State University, United States

Dr. Dukagjin M. Blakaj, MD, PhD, is a distinguished physician-scientist and academic leader in radiation oncology, specializing in proton therapy. Currently serving as the Vice Chair of Clinical Operations and holding the prestigious Drs. Malati and Ganesh Potdar Endowed Professorship at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital, he brings visionary leadership in patient-centered oncology care. With dual degrees in medicine and biochemistry, Dr. Blakaj integrates clinical expertise with advanced translational research. He is renowned for developing innovative radiotherapy protocols, advancing artificial intelligence applications in oncology, and mentoring future clinician-scientists. His work significantly influences treatment outcomes for head and neck cancers, including HPV-related oropharyngeal cancer, and is published in top-tier journals. A respected thought leader and collaborative partner, Dr. Blakaj embodies excellence in academic medicine, multidisciplinary team leadership, and compassionate patient care.

Publication Profile: 

Google Scholar

Scopus

Orcid

Education:

Dr. Blakaj’s educational path is both extensive and interdisciplinary. He earned his MD, PhD, and MS in Biochemistry from the Albert Einstein College of Medicine in New York, where he focused on molecular interactions in biological systems. Before that, he completed both a BA in Chemistry and Molecular Biology & Biophysics and an MA in Chemistry from Wesleyan University in Middletown, CT. His doctoral work explored protein-RNA interactions, laying the groundwork for his scientific rigor and precision. This strong biochemical foundation supports his innovative clinical research in radiation oncology and immunotherapy. His education highlights a consistent pattern of academic excellence and intellectual curiosity, equipping him with a rare blend of clinical insight and research acumen that continues to impact cancer treatment paradigms worldwide.

Professional Experience:

Dr. Dukagjin Blakaj is the Vice Chair of Clinical Operations in Radiation Oncology and Drs. Malati and Ganesh Potdar Endowed Professor in Proton Therapy at OSUCCC – James Cancer Hospital. As a senior faculty member, he has led transformative improvements in clinical care, quality assurance, and translational oncology research. His multidisciplinary collaboration extends across surgery, radiology, oncology, and data science, driving innovations such as AI-guided treatment protocols and digital health integration. Dr. Blakaj has also played a critical role in operationalizing proton therapy and implementing personalized cancer therapies. His background spans high-impact clinical trials, program development, and mentorship. The combination of clinical leadership and academic scholarship positions him as a strategic thinker with practical, evidence-driven execution. His commitment to precision medicine and patient-centered care distinguishes him among modern radiation oncologists.

Awards and Honors:

Dr. Blakaj has received numerous accolades that reflect his clinical excellence, research innovation, and service to the academic community. Notably, he was awarded the Drs. Malati and Ganesh Potdar Endowed Professorship in Radiation Oncology – Proton Therapy (effective June 2025), the highest honor granted by Ohio State University. His ABR Volunteer Service Award (July 2025) highlights his contributions to professional standards and education. He was selected for the James Outstanding Physician Peer Award for exemplary leadership, professionalism, and collaboration (August 2024). Additionally, his abstract ranked in the Top 7 of 146 presentations at ACRO, underscoring his research’s national impact. Dr. Blakaj’s consistent recognition across service, research, and teaching is a testament to his dedication, integrity, and influence in the field of oncology.

Research Focus:

Dr. Blakaj’s research is centered on optimizing cancer treatment outcomes through precision radiation therapy, immunotherapy integration, and the application of artificial intelligence in oncology. He focuses primarily on head and neck cancers, with additional emphasis on HPV-associated oropharyngeal carcinoma, FLASH radiotherapy, and treatment response prediction using circulating tumor DNA and inflammatory indices. He co-leads interdisciplinary studies leveraging machine learning, big data, and digital health tools to personalize care and reduce treatment toxicity. His research is both translational and clinically grounded, often influencing national clinical practice guidelines and multi-center trials. As a key contributor to high-impact publications, Dr. Blakaj has established himself as a thought leader in adaptive radiotherapy and survivorship outcomes. His pioneering work in proton therapy protocols and patient-reported outcomes continues to bridge the gap between innovative science and practical oncology care.

Publications Top Notes: 

  1. An integrated ML-based prognostic model in head and neck cancer using inflammatory markers and financial toxicity

  2. Vertebral endplate disruption and compression fracture risk: Expanded radiotherapy analysis

  3. Nasopharyngeal carcinoma in nonendemic regions: Characteristics and treatment outcomes

  4. Emerging paradigms in radiation oncology: Evolution and patient-centric care

  5. FLASH radiotherapy: From in vivo data to clinical translation

  6. Digital health tools in radiation oncology: Development and implementation review

  7. ctDNA as a response marker in HPV-associated oropharyngeal carcinoma: A pilot study

  8. AI, machine learning, and big data in radiation oncology

  9. Predicting cisplatin tolerability in elderly head and neck cancer patients

  10.  Tobacco, marijuana, and alcohol use impact on survival in metastatic head and neck cancer

Conclusion:

Dr. Dukagjin M. Blakaj is a highly qualified, forward-thinking researcher whose body of work exemplifies excellence in translational oncology. He brings together advanced clinical practice, cutting-edge research, and visionary leadership to improve cancer care outcomes and drive future innovations in radiation therapy.

Given his sustained productivity, multidisciplinary leadership, and contributions to patient-centered care models, Dr. Blakaj is a deserving and outstanding nominee for the Best Researcher Award.

Marco Leitzke | immunology | Best Researcher Award

Published on by Cell Biologist

Dr. Marco Leitzke | immunology | Best Researcher Award

Dr. Marco Leitzke, Helios clinics, Germany

Dr. Marco Leitzke, born in 1970 in Karl-Marx-Stadt, Germany, is a senior anesthesiologist and pioneering researcher in neuromodulation and post-viral syndromes. He has served as Senior Consultant in Anesthesiology and Intensive Care at Helios Clinic Leisnig since 2015 and has extensive experience in pain therapy and palliative medicine. Renowned for his innovative studies on autonomic dysfunction, Dr. Leitzke has published extensively on cholinergic neurotransmission, COVID-19 coagulopathy, and vagus nerve stimulation. His recent focus on Long COVID as a disorder of disrupted acetylcholine signaling has gained significant scientific attention. With a dual career in clinical practice and experimental research, he bridges the gap between bedside and bench. His work earned him accolades, including a Poster Award at the 1st Long COVID Congress in Jena. Passionate about translational medicine, Dr. Leitzke continues to drive forward the understanding and treatment of complex neuroimmune disorders.

Publication Profile: 

Google Scholar

Scopus

Education:

Dr. Leitzke’s medical education and specialization reflect a deep commitment to anesthesiology and neurobiological research. He became a board-certified specialist in anesthesiology in 2006 and has built on this foundation with focused training in advanced pain management, ultrasound-guided interventions, and emergency medicine. He undertook specialized pain therapy training in 2015 and interventional pain techniques in 2014. In 2019, he began training as an Antibiotic Stewardship (ABS) expert physician, further demonstrating his holistic approach to patient safety and infection control. He also completed a transthoracic echocardiography course in 2018, showcasing his commitment to continuous learning and cross-disciplinary skills. This diverse academic background provides the basis for his translational research into neuroimmune and autonomic disorders, with a strong emphasis on clinical application. His combination of anesthesiology, ultrasound, pain therapy, and experimental neurobiology positions him as a uniquely skilled researcher bridging clinical practice and neuroscience.

Experience:

Dr. Marco Leitzke brings over two decades of clinical experience, predominantly in anesthesiology, intensive care, pain therapy, and palliative medicine. Since 2015, he has held the position of Senior Consultant at the Helios Clinic in Leisnig, where he leads interdisciplinary efforts in patient care and clinical innovation. Prior to this, he served as Senior Consultant at Asklepios Clinic Weißenfels from 2011 to 2014, while also operating as a freelance physician in Zeitz. His professional focus spans acute and chronic pain, complex anesthesia procedures, and critical care management, underpinned by a solid emergency medicine foundation gained since 2001. His hands-on experience with ultrasound-guided interventions, vagal modulation therapies, and autonomic diagnostics directly informs his research into the pathophysiology of post-viral syndromes. The integration of clinical insight and scientific exploration marks him as a dual-domain expert, fostering new therapeutic approaches rooted in both laboratory evidence and patient outcomes.

Research Focus:

Dr. Leitzke’s research centers on cholinergic neurotransmission and its impairment in acute and chronic post-viral conditions, particularly Long COVID. His central hypothesis suggests that autonomic dysfunction and neuromodulatory imbalance—specifically, disruption of the vagus nerve and acetylcholine pathways—underlie many post-viral symptoms. Through translational models using animal studies and human imaging, he explores therapeutic modulation, including vagal nerve stimulation and nicotine administration, to restore autonomic balance. His research extends to the role of NF-κB activation in COVID-19-associated coagulopathy, suggesting molecular pathways that link inflammation, clotting, and neuroimmune dysfunction. A hallmark of his work is the use of advanced imaging techniques (e.g., PET scans) to quantify cerebral receptor activity, particularly α7 nicotinic acetylcholine receptors. This integrative and experimental approach offers new perspectives on diagnostics and treatment in neuroimmune conditions, making his work highly relevant to both the scientific and medical communities in the era of post-COVID syndromes.

Publications Top Notes:

  1. 📖 Long COVID – A Critical Disruption of Cholinergic Neurotransmission? (Springer Nature, 2025)

  2. 📖 Is the Post-COVID-19 Syndrome a Severe Impairment of Acetylcholine-Orchestrated Neuromodulation That Responds to Nicotine Administration? (Springer Nature, 2023)

  3. 🏅 COVID-19 – The Ultimate NF-κB Rush and the Crucial Importance of Nicotinic Acetylcholine Receptors (Poster Award, Long COVID Congress, 2022)

  4. 🔬 Experimental Design for PET Detection of α7nAChR Under Gastric Vagus Nerve Stimulation in Piglets (DAS PLUS AN SCHUTZ, 2022)

  5. 🧠 The Viral Accelerated NF-κB Pathway and COVID-19-Associated Coagulopathy – A Case Report (Fortune Journals, 2021)

  6. 🧪 Afferent Vagal Stimulation via Gastric Electrical Stimulation Alters Sympathetic-Vagal Balance in Pigs – A Pilot Trial (Journal of Biological Regulators, 2021)

  7. ⚖️ Autonomic Balance Determines the Severity of COVID-19 Courses (Springer Nature, 2020)

  8. 🧮 A Semi-Automated Algorithm for Hypothalamus Volumetry in 3 Tesla MRI (Psychiatry Research: Neuroimaging, 2018)

  9. 🧬 Image-Derived Input Function for (-)-[18F]Flubatine Using a Digital PET System (European Journal of Nuclear Medicine, 2024)

  10. 💊 What Is the Impact of Nicotine on the Post-COVID-19 Syndrome? – A Case Series (Preprint, 2025)

Conclusion:

Dr. Marco Leitzke is a highly deserving candidate for the Best Researcher Award due to his pioneering contributions to understanding and treating Long COVID and neuroimmune disorders. His strong publication record, interdisciplinary approach, and clinical insight mark him as a leading figure in his field. With enhanced international collaboration and clinical validation of his findings, his impact could be even greater. Overall, his research is timely, innovative, and of substantial scientific and societal importance.

Michel Manika Muteya | Microbial Cell Biology | Best Researcher Award

Published on by Cell Biologist

Dr. Michel Manika Muteya | Microbial Cell Biology | Best Researcher Award

Dr. Michel Manika Muteya, Faculty of Medicine, University of Lubumbashi, Congo, Democratic Republic of the

Dr. Michel Manika Muteya is a seasoned Congolese physician, specializing in Anesthesiology, Intensive Care, and Emergency Medicine. Born in Lubumbashi on September 5, 1972, he has dedicated over two decades to both clinical excellence and academic research. As Head of the Anaesthesiology-Intensive Care Department at the University Teaching Hospital of Lubumbashi since 2013, Dr. Muteya is recognized for advancing critical care practices in resource-limited settings. His scientific contributions, spanning over 20 peer-reviewed publications, tackle pressing health issues like sepsis, tuberculosis, transfusion medicine, and maternal care. A married father of five, he balances his demanding career with strong family values. With a collaborative spirit and global engagements, he contributes to large-scale studies including the ASOS-2 Lancet Trial, reflecting his impact in African surgical safety. His leadership and evidence-based approach make him a top contender for the Best Researcher Award.

Publication Profile: 

Orcid

Education:

Dr. Michel Muteya Manika received his Doctor of Medicine (MD) degree after completing an intensive medical program that included a year-long rotating internship (2003–2004) at Sendwe Hospital in Lubumbashi, covering internal medicine, pediatrics, surgery, and gynecology. He further honed his skills through a professionalization internship in General Medicine at the Ruashi Military Hospital (HMR) from November 2004 to May 2005. His specialization journey led him into the field of Anesthesiology and Intensive Care, where he developed key competencies in transfusion medicine, disaster medicine, and emergency response. In parallel, he has continually upgraded his academic profile by engaging in international conferences, research collaborations, and multi-country studies. His educational path reflects a strong clinical foundation coupled with academic curiosity, enabling him to bridge practical medicine with impactful research in sub-Saharan Africa.

Experience:

Dr. Michel Manika Muteya has served as the Head of Anaesthesiology and Intensive Care at the University Teaching Hospital of Lubumbashi since 2013. His leadership has driven improved patient outcomes and department-wide protocols, especially for sepsis, trauma, obstetric emergencies, and postoperative care. His hands-on training began with internships in internal medicine, pediatrics, surgery, and gynecology, followed by a professionalization period at a military hospital. With more than 20 years of clinical and academic experience, Dr. Muteya has also contributed to policy and training reforms in anesthesia education, collaborating with international teams in Rwanda and beyond. He’s a mentor, educator, and published researcher, involved in critical studies related to infectious diseases, HIV, malaria, and emergency care readiness. His commitment to healthcare in resource-limited environments underlines his passion for equitable, safe, and effective care, making his career a beacon of medical excellence in Central Africa.

Research Focus:

Dr. Michel Muteya Manika’s research primarily focuses on critical care medicine in low-resource settings, with specific interests in sepsis management, transfusion medicine, anesthetic safety, and infectious diseases such as tuberculosis and HIV. He investigates both the clinical and epidemiological aspects of disease patterns in the Democratic Republic of Congo, often exploring how infrastructure limitations affect care outcomes. His work extends to maternal and pediatric emergencies, post-operative surveillance, and clinical education reform, including developing curricula for anesthesiology clerkships in Africa. He collaborates widely across disciplines and borders, contributing to high-impact journals like The Lancet Global Health, BMC Health Services Research, and Pan African Medical Journal. A champion of evidence-based practice, Dr. Muteya seeks to align global standards with local realities, enhancing emergency response systems and training the next generation of African clinicians. His applied, context-specific research offers real-world solutions to systemic healthcare challenges.

Publications Top Notes: 

  1.  Prognosis of Tetanus Patients in ICU – Sendwe Hospital, Lubumbashi

  2.  Epidermoid Carcinoma of the Vulva in Twin Pregnancy – Case Report

  3.  Tuberculosis Revealed by Thrombocytopenic Purpura in a Child

  4.  Anemias in Pediatric Emergencies – 632 Cases Study

  5.  Peripheral Lymphadenopathy: Tertiary Center Study

  6.  Cytopathological Profile of Lymphadenopathies – 13 Cases

  7.  Malaria/HIV Coinfection Profile in Lubumbashi Adults

  8.  Seroprevalence of Blood Donors – University Clinics of Lubumbashi

  9.  Tuberculosis Profile in Lubumbashi Health Zone

  10.  Anesthesia Practices in Lubumbashi – Patient and Surgery Types

Conclusion:

Dr. Michel Manika Muteya is highly suitable for the Best Researcher Award. He combines clinical leadership, regional relevance, and consistent academic output in fields critical to healthcare improvement in Africa. His research addresses real-world health crises—sepsis, HIV, TB, surgical safety—through practical, evidence-based approaches. With a balance of hands-on expertise and scholarly excellence, he represents the ideal candidate whose work has both academic rigor and societal impact. Minor expansions in global visibility and technological integration would elevate his already impressive career to even greater heights.

Jebunnahar Khandakar | Biological Sciences | Best Researcher Award

Published on by Cell Biologist

Dr. Jebunnahar Khandakar | Biological Sciences | Best Researcher Award

Dr. Jebunnahar Khandakar, Independent University, Bangladesh, Bangladesh

Dr. Jebunnahar Khandakar is an accomplished academic and researcher specializing in environmental science, plant physiology, and biotechnology. Currently serving as an Associate Professor in the Department of Life Sciences at Independent University, Bangladesh, she brings extensive expertise in sustainable agriculture and mushroom biotechnology. She earned her PhD from Nagasaki University, Japan, with a focus on plant-environment interactions and proteomics. Over her career, Dr. Khandakar has contributed significantly to research in mushroom cultivation, environmental sustainability, and food system innovations. Her work has been published in renowned journals, reflecting her commitment to developing practical, affordable, and eco-friendly solutions for agricultural improvement. She has also provided consultancy for global initiatives, including work with the UNCCD. Dr. Khandakar’s dedication to research and community impact makes her a strong candidate for recognition as a Best Researcher Award recipient.

Publication Profile: 

Google Scholar

Scopus

Orcid

Education:

Dr. Jebunnahar Khandakar’s educational background demonstrates a strong foundation in biotechnology and environmental science. She earned her Doctor of Philosophy (PhD) in September 2013 from Nagasaki University, Japan, where she focused on plant physiology and biotechnology, specifically analyzing stress responses and secondary metabolism in plants. Prior to that, she completed her MS in Biotechnology in July 2005 from Bangladesh Agricultural University with an excellent academic record (Grade A). Her MS research delved into mycelial growth and spawn production, forming the basis for her long-term interest in fungal biology. These degrees have equipped her with expertise in both applied and fundamental biosciences, particularly in sustainable crop production and biotechnological applications for food and environmental security. Her strong academic background supports her ongoing contributions to science through teaching, mentoring, and pioneering research projects.

Experience:

Dr. Jebunnahar Khandakar has nearly two decades of combined experience in academia and applied environmental science. She is currently an Associate Professor at Independent University, Bangladesh (IUB), where she has served since 2016, being promoted in September 2024. At IUB, she teaches and supervises students in plant biotechnology, environmental biology, and sustainable agriculture. Before her academic tenure, she served as a Junior Consultant for the United Nations Convention to Combat Desertification (UNCCD) at the Department of Environment in Dhaka, where she contributed to policy frameworks for sustainable land use and biodiversity conservation. Her role involved integrating scientific research into national strategies, further enriching her interdisciplinary understanding. Dr. Khandakar’s career trajectory highlights her ability to bridge academic knowledge with field applications, aligning science with real-world agricultural and environmental challenges.

Research Focus:

Dr. Khandakar’s research primarily centers on sustainable agriculture, environmental biotechnology, and fungal physiology. Her work spans optimizing substrates for mushroom cultivation, improving post-harvest shelf life, and exploring biowaste as cultivation media. She also explores molecular and physiological responses of medicinal plants like Hyoscyamus albus under abiotic stresses, including nutrient deficiencies and metal toxicity. Through proteomics and biochemistry, she investigates root signaling, riboflavin biosynthesis, and stress-induced metabolite changes. Recently, her research has shifted to low-cost, eco-friendly solutions for food production—developing nitrogen gas packaging for mushrooms and assessing market chains for semi-fermented fish. Her interdisciplinary approach blends biotechnology with environmental sustainability, aiming to improve nutrition, soil health, and farmer livelihoods. This diverse yet focused research portfolio underlines her impact and innovation in agricultural and life sciences, with clear contributions toward climate-smart and affordable food technologies.

Publications Top Notes: 

  1. Using spent mushroom substrate (SMS) as a casing boosted bacterial activity and enhanced the mineral profile of Calocybe indica.

  2. Deciphering the Role of Substrate C/N Ratio in Preventing Orange Mold Contamination in Mushroom Cultivation.

  3. Establishment of a Simple Single Spore Isolation Method for Gilled Mushroom Research.

  4. Optimizing Tea Waste as a Sustainable Substrate for Oyster Mushroom Cultivation.

  5. Packaging with Nitrogen Gas Enhanced Shelf-Life of Fresh Oyster Mushrooms.

  6. Exploring the Market Value Chain Dynamics of Chepa (Semi-Fermented Fish).

  7. Shelf-life Evaluation of Oyster Mushrooms using Different Packaging Materials and Storage Conditions.

  8. Survey on Technical Efficacy and Farmer Satisfaction for Onion Seed Production in Rajshahi.

  9. Extraction and Fractionation of Subproteome from Hyoscyamus albus Root Tips.

  10.  Reducing Pesticide Use in Cucumber Cultivation via Environment-Friendly Technology.

Conclusion:

Dr. Jebunnahar Khandakar is highly deserving of the Best Researcher Award. Her work is innovative, impactful, and highly aligned with real-world agricultural challenges—particularly in low-cost, sustainable food production methods and environmental biotechnology. She has demonstrated academic excellence, field application, and research leadership over the years, both nationally and internationally.

Catherine Stanton | Microbiome | Best Researcher Award

Published on by Cell Biologist

Prof. Catherine Stanton | Microbiome | Best Researcher Award

Prof. Catherine Stanton, Teagasc Food Research Centre, Ireland

Prof. Catherine Stanton is a globally recognized expert in nutrition, microbiology, and food science, currently serving as a Senior Principal Research Officer at Teagasc Moorepark, Ireland, and Research Professor at University College Cork. With an H-index of 135 (Google Scholar), her groundbreaking work in probiotics, gut microbiota, and dairy science has made substantial contributions to human and animal health. She is a Principal Investigator at APC Microbiome Ireland, shaping key insights into microbial-host interactions. Prof. Stanton’s interdisciplinary expertise spans biochemistry, food bioscience, and microbiome research, making her a leader in functional foods innovation. Over her career, she has authored hundreds of publications, filed multiple patents, and earned global recognition as a highly cited researcher. She is renowned for translating science into applications in nutrition and health, benefiting industries and public health policies alike.

Publication Profile: 

Scopus

Education:

Prof. Stanton holds a distinguished academic background rooted in nutrition and biochemistry. She earned her B.Sc. in Nutrition & Food Chemistry from University College Cork (UCC) in 1983, achieving second-class honours (2.1). She followed this with an M.Sc. in Nutrition at UCC in 1986, gaining a deeper understanding of food-based health science. In 1988, she completed her Ph.D. in Biochemistry at Bournemouth University, UK, focusing on molecular and functional biochemistry. Her pursuit of academic excellence culminated in receiving a D.Sc. from the National University of Ireland in 2009, a testament to her lifetime achievements in research. These academic milestones laid the foundation for her multidisciplinary approach, bridging nutrition, microbiology, and food technology to tackle pressing health challenges. Her educational journey reflects both depth and breadth, enabling her to excel in academic research, innovation, and international collaboration.

Experience:

Prof. Stanton has over three decades of impactful research and leadership in microbiology and nutrition. Since 2018, she has served as Senior Principal Research Officer at Teagasc Moorepark, Ireland’s leading agri-food research institute. She is also a Research Professor at University College Cork (UCC) and a Principal Investigator at APC Microbiome Ireland since 2003, where she spearheads cutting-edge research into gut microbiota, probiotics, and host health. Her academic career is complemented by her industrial collaborations, public policy contributions, and work with global health organizations. Prof. Stanton’s innovative patents and translational science have impacted sectors ranging from dairy to pharmaceuticals. She has mentored countless students and professionals while representing Ireland on international expert panels such as the FAO/WHO Probiotics Consultation. Her tenure showcases a rare blend of scientific excellence, leadership, and collaborative prowess.

Awards and Honours:

Prof. Stanton has received numerous prestigious accolades for her scientific contributions. She was named a Highly Cited Researcher by Web of Science (Clarivate Analytics) from 2017 to 2024, placing her among the top 1% globally in Agricultural Science and Microbiology. In 2020, she was honoured with the Distinguished Service Award by the American Dairy Science Association (ADSA), recognizing her lifetime achievements. In 2019, she was declared Scientist of the Year at the Irish Laboratory Awards, acknowledging her leadership in microbiome and functional foods research. She also served as Rapporteur for the FAO/WHO Expert Consultation on Probiotics in Food (2001), contributing to global food health policies. Her awards reflect not only the depth of her research but also its real-world impact in agriculture, nutrition, and global health policy, making her a standout in interdisciplinary scientific leadership.

Research Focus:

Prof. Stanton’s research centers on functional foods, probiotics, and the gut microbiome, focusing on their roles in human and animal health. Her work investigates the mechanisms of beneficial microbes, particularly how they influence immune function, intestinal integrity, and disease prevention. She has pioneered research on conjugated linoleic acids, probiotic cheese development, and bacteriocin-producing strains that combat pathogens. At APC Microbiome Ireland, she leads projects exploring maternal and infant gut health, developing microbiota-based strategies for conditions ranging from diarrhea to cancer. Her research is highly translational, often leading to patents and industry applications in food biotechnology and pharmaceuticals. She collaborates across disciplines—biochemistry, microbiology, and nutrition—to develop evidence-based dietary interventions. With a strong publication record and global influence, her research has set benchmarks in microbiome science, making her a leader in shaping next-generation health strategies.

Publications Top Notes: 

  1. Leuconostoc lactis strain APC 3969 produces a new variant of cyclic bacteriocin leucocyclicin Q and displays potent anti-Clostridium perfringens activity

  2. Bacteroides maternus sp. nov., a novel species isolated from human faeces

  3. Gut and oral microbial profile associations to oral cancer

  4. Bifidobacterium longum subsp. infantis modulates intestinal immunity in growing mice in a strain-specific manner

  5. Exploring tarhana’s prebiotic potential using different flours in an in vitro fermentation model

  6. Lactiplantibacillus plantarum CCFM8661 improves intestinal barrier function and regulates gut microbiota to alleviate enterotoxigenic E. coli-induced diarrhea in mice

  7. Rebuttal to Gut Microbiome in Children with Congenital Heart Disease After Cardiopulmonary Bypass Surgery (GuMiBear Study)

  8. Correction to: Examining the healthy human microbiome concept

  9. Examining the healthy human microbiome concept

  10. Streptococcus wuxiensis, S. jiangnanensis, and S. fermentans: three novel species isolated from human breast mil

Conclusion:

Prof. Catherine Stanton is eminently suitable for the Best Researcher Award, based on her scientific excellence, real-world impact, and global recognition. Her body of work demonstrates visionary leadership, interdisciplinary collaboration, and a legacy of innovation in probiotics and microbiome science. With unmatched citation metrics, patent contributions, and public service roles, she stands as a role model for both established and upcoming researchers.

Hansong Dong | Host-Pathogen Interactions | Best Researcher Award

Published on by Cell Biologist

Prof. Hansong Dong | Host-Pathogen Interactions | Best Researcher Award

Prof. Hansong Dong, Shandong Agricultural University, China

Dr. Hansong Dong is a distinguished Professor of Plant Pathology and Doctoral Supervisor at Shandong Agricultural University, China. With a Ph.D. in Plant Pathology, his work spans over four decades, focusing on plant immunity, signal transduction, and the balance between crop growth and defense. A renowned researcher and published poet, Prof. Dong has made seminal contributions to our understanding of aquaporins, hormone signaling, and the molecular interface between host plants and pathogens. His international academic exposure, including time as a Visiting Scholar at Cornell University, has further enriched his scientific insights. In addition to his impactful research, Prof. Dong has mentored numerous graduate students and contributed to agricultural innovation. With numerous high-impact publications in journals like Molecular Plant and New Phytologist, his work is widely recognized. Beyond academia, his literary works reflect a philosophical appreciation of nature and resilience, exemplifying a rare integration of science and art.

Publication Profile: 

Scopus

Education:

Prof. Hansong Dong pursued his undergraduate studies in Plant Protection at Shandong Agricultural University (1978–1982). He continued with his Master’s and Ph.D. in Plant Pathology at Nanjing Agricultural University, completing them in 1985 and 1988, respectively. His academic training provided a solid foundation in plant-microbe interactions, molecular biology, and host defense mechanisms. During his studies, he honed his focus on understanding plant immune responses, laying the groundwork for his future breakthroughs in signaling and aquaporin-mediated defense. His Ph.D. thesis contributed to early models of pathogen-host dynamics in crops, marking the start of a lifelong research trajectory in agricultural biotechnology. His formal education not only established his credibility in plant pathology but also shaped his vision for interdisciplinary research. Prof. Dong’s academic excellence has continued to drive forward key discoveries in the field, making him a leading authority in crop protection and molecular plant immunity in China and internationally.

Experience:

Prof. Dong began his career as a Lecturer in the Department of Plant Pathology at Shandong Agricultural University (1988–1993). He quickly rose through academic ranks—Associate Professor in 1993, and full Professor by 1994. His leadership and research capabilities were recognized early on, leading to a Visiting Scholar position at Cornell University (1997–2000), where he engaged in collaborative projects on plant immune signaling and pathogen effectors. Over his decades of teaching and research, Prof. Dong has supervised numerous doctoral students, published extensively, and shaped academic policy and curriculum in plant pathology. His tenure at Shandong Agricultural University is marked by scientific rigor, mentorship, and impactful agricultural innovations. His ability to bridge laboratory research with field application has contributed significantly to crop disease management strategies in China. Prof. Dong remains actively involved in national and international research initiatives, playing a vital role in advancing molecular plant pathology and crop resilience.

Awards & Honors:

Prof. Hansong Dong has received several prestigious accolades recognizing his early and sustained contributions to science and education. In 1992, he was honored as an Outstanding Young Intellectual and received the Shandong Youth Science and Technology Award, acknowledging his early promise in agricultural research. The same year, he was also named an Excellent Young Teacher, a testament to his pedagogical contributions. In 1993, he was recognized as a New Long March Commando, symbolizing excellence in youth-led scientific advancement in China. These early recognitions paved the way for a prolific academic career that has garnered respect across disciplines. His awards highlight his leadership in scientific innovation, commitment to nurturing the next generation of researchers, and the societal relevance of his work in safeguarding global food security. As both a scientist and educator, Prof. Dong’s accolades reflect his well-rounded excellence and continued influence in plant pathology and agronomic science.

Research Focus:

Prof. Dong’s research focuses on signal transduction in plant disease resistance and the regulation of growth-defense trade-offs in crops. His work investigates the molecular dialogue between plants and pathogens, particularly through the lens of aquaporins, importins, and membrane proteins. He has significantly advanced our understanding of how pathogenic effectors manipulate host splicing and hormone pathways, notably through TAL effectors and NPR1/NPR3 systems in rice. His team applies multi-omics and CRISPR-based editing to engineer resistant crops while minimizing yield penalties, a critical goal in sustainable agriculture. By elucidating the roles of H2O2 transport, type-III secretion systems, and transcriptional regulation, his research offers translational solutions to fungal and bacterial diseases in cereals like rice and wheat. Prof. Dong’s innovative blend of molecular biology, bioinformatics, and field experimentation drives progress toward disease-resilient, high-yield crops. His collaborative, systems-level approach continues to shape modern plant pathology and crop biotechnology.

 Publications Top Notes:

  1. Alternative splicing of OsNPR3… enhances disease susceptibility in rice – Molecular Plant, 2025

  2. Plant PI4P is required for bacteria to translocate type-3 effectors – New Phytologist, 2025

  3. MYB44 regulates PTI via EIN2 and MPK3/6 in Arabidopsis – Plant Communications, 2023

  4. Importin β1 mediates nuclear entry of EIN2C against aphids – IJMS, 2023

  5. Phosphorylation of wheat aquaporin enhances growth and defense – Molecular Plant, 2022

  6. Aquaporin OsPIP2;2 links H2O2 signaling to plant defense – Plant Physiology, 2022

  7. Editing rice importin IMPα1b sequesters TAL effectors – Phytopathology Research, 2022

  8. Aquaporin modulation intensifies photosynthesis and disease resistance – Plant Journal, 2021

  9. OsPIP2;2 facilitates drought tolerance in rice – Plant Direct, 2021

  10.  Aquaporin TaPIP2;10 confers dual fungal resistance in wheat – Phytopathology, 2021

Conclusion:

Prof. Hansong Dong is highly suitable for the “Best Researcher Award.” His scholarly depth, sustained academic leadership, groundbreaking findings in plant pathology, and dedication to mentoring make him a standout candidate. His career exemplifies a blend of scientific rigor, poetic vision, and global relevance. Recognizing Prof. Dong would not only honor an exceptional researcher but also inspire younger generations in the intersection of science and humanity.

Takwa Wannassi | Plant pathology | Best Researcher Award

Published on by Cell Biologist

Dr. Takwa Wannassi | Plant pathology | Best Researcher Award

Dr. Takwa Wannassi, CRRA Sidi Bouzid, Tunisia

Dr. Takwa Wannassi is a dedicated plant protection specialist and postdoctoral researcher at the Regional Center of Agricultural Research in Sidi Bouzid, Tunisia. With a Ph.D. in Plant Protection and Environment and an Engineering Degree in Horticulture, she brings advanced expertise in entomology, plant-microbe interactions, and sustainable agriculture. Her work is primarily focused on integrated pest management and ecological approaches to crop protection, particularly in Mediterranean agroecosystems. Dr. Wannassi has authored several impactful scientific publications and has contributed significantly to the understanding of invasive pest dynamics, particularly the apricot seed wasp. She plays a crucial role in the international PRIMA project “REVINE,” where she coordinates field trials, mentors students, and collaborates across scientific disciplines. Her dedication to sustainable farming solutions, her extensive research record, and her collaborative spirit make her a strong candidate for the Best Researcher Award.

Publication Profile: 

Google Scholar
Scopus
Orcid

Education:

Dr. Takwa Wannassi holds a Ph.D. in Plant Protection and Environment from Sousse University, Higher Institute of Agronomic Sciences of Chott Mariem (ISA-CM), completed in December 2022. Her doctoral work centered on invasive species and sustainable pest management in Tunisia, particularly the apricot seed wasp Eurytoma samsonowi. She also holds an Engineer Degree in Horticulture with a specialization in Plant Protection, earned in July 2017 from the same institution. Her academic journey reflects a consistent focus on understanding ecological challenges in agriculture and developing innovative, sustainable solutions. Through both degrees, she acquired hands-on skills in molecular biology, field experimentation, pest identification, and biological control. Her academic excellence laid the foundation for her impactful contributions in agricultural research and sustainability science in the Mediterranean region.

Experience:

Since January 2025, Dr. Takwa Wannassi has been serving as a postdoctoral fellow at the Regional Center of Agricultural Research in Sidi Bouzid (CRRA), Tunisia, contributing to the international PRIMA Project “REVINE.” Her responsibilities include coordinating the research project, supervising graduate students, conducting field and lab trials, and analyzing data using R. Her work spans genomic analysis, molecular diagnostics, pest ecology, and microbiome studies. Previously, during her Ph.D., she gained extensive experience in pest ecology, molecular biology, and entomology, particularly in relation to invasive pests such as Eurytoma samsonowi. Dr. Wannassi also collaborates with international institutions, including during a research fellowship in Canada. She is proficient in preparing scientific publications and has presented her findings at major international conferences. Her multidisciplinary approach and leadership in sustainable agriculture research have earned her recognition at both national and international levels.

Awards and Honors:

Dr. Takwa Wannassi has received several accolades in recognition of her contributions to agricultural science and research. In 2019, she earned the Best Poster Award at the Tunisia-Japan Symposium on Science, Society and Technology (TJASSST) for her research on pest behavior and pheromone-based management strategies. That same year, she was granted a Research Fellowship in Canada, allowing her to work at the University of Victoria, British Columbia for two months, enhancing her international research exposure and collaboration. Her continuous efforts in sustainable pest management, microbiome studies, and plant-pathogen interaction have positioned her as a promising researcher in plant protection. She is frequently invited to contribute to scientific conferences and peer-reviewed journals. Her achievements underline her scientific innovation, dedication to eco-agriculture, and her potential as a future leader in Mediterranean agricultural research.

Research Focus:

Dr. Takwa Wannassi’s research centers on plant protection, pest ecology, biological control, and plant-microbiome interactions, with a strong focus on sustainability. Her main scientific interest lies in understanding the behavior and biology of invasive pests like Eurytoma samsonowi, a major threat to apricot production in Tunisia. She utilizes molecular tools, including 16S rRNA sequencing, to explore bacterial communities and Wolbachia infections in pest populations. Additionally, she investigates the role of beneficial rhizobacteria and microbial consortia in disease suppression and grapevine health as part of the PRIMA “REVINE” project. Through multidisciplinary approaches, she integrates entomology, microbiology, and bioinformatics to develop innovative pest management strategies aligned with climate-smart agriculture. Her goal is to promote ecosystem services, biodiversity, and resilience in Mediterranean cropping systems through regenerative and eco-friendly practices.

Publications Top Notes: 

  1. Insights on the bioecology of the invasive apricot seed wasp Eurytoma samsonowi in Tunisia (Biologia, 2023)

  2. Emergence of the apricot seed wasp Eurytoma samsonowi as an economic pest of apricots in Tunisia (Phytoparasitica, 2022)

  3. Prevalence of Wolbachia infection in field populations of the apricot seed wasp (International Microbiology, 2024)

  4. Exploration of bacterial composition and diversity within Eurytoma samsonowi via 16S rRNA sequencing (Symbiosis, 2025)

  5. Harnessing a Microbial Consortium and Compost to Control Grapevine Pathogens (Horticulturae, 2025)

  6. Investigating the potential role of beneficial rhizobacteria for grapevine health and growth (Frontiers in Sustainable Food Systems, 2025)

  7. Biocontrol Assessment of Trichoderma Species on Tomato Crops Infested by Curvularia Spicifera (Frontiers, 2025)

  8. Divergent bacterial abundance and diversity in Eurytoma samsonowi revealed by 16S rRNA (Biochem & Microbiology Congress)

  9. Assessment of damage by Eurytoma samsonowi on apricot fruits in Tunisia (INAT Symposium Poster, 2018)

  10.  Delta traps with virgin females attract Eurytoma samsonowi males: Pheromone control potential (TJASSST, 2019)

Conclusion:

Dr. Takwa Wannassi is an emerging leader in plant protection and agroecology, with a proven record of excellence in research, publishing, and project management. Her work on invasive pest control, microbial consortia, and regenerative viticulture directly addresses critical challenges in Mediterranean and global agriculture. Her multidisciplinary approach, international recognition, and active mentorship highlight her readiness for continued leadership in science. She is highly suitable and deserving of the Best Researcher Award, as she exemplifies innovation, academic rigor, and a commitment to sustainable agricultural development.

Cesare Orlandi | GPCR signaling pathways | Best Researcher Award

Published on by Cell Biologist

Assoc. Prof. Dr. Cesare Orlandi | GPCR signaling pathways | Best Researcher Award

Assoc. Prof. Dr. Cesare Orlandi, University of Rochester, United States

Dr. Cesare Orlandi is an accomplished Associate Professor of Pharmacology and Physiology at the University of Rochester School of Medicine & Dentistry. With a multidisciplinary background in pharmaceutical biotechnology and molecular genetics, Dr. Orlandi has made significant contributions to GPCR (G protein-coupled receptor) biology, orphan receptor deorphanization, and signal transduction. His work bridges basic molecular pharmacology with translational applications in neuroscience and immunology. He has authored numerous high-impact publications in leading journals like Science, Nature Communications, and Journal of Medicinal Chemistry. His collaborative research with global institutions reflects a strong network and broad scientific reach. Recognized for his excellence in science communication, Dr. Orlandi has received multiple “Best Talk” awards at competitive research symposia. His lab continues to innovate at the frontier of receptor biology, influencing therapeutic strategies in neurobiology and inflammation.

Publication Profile: 

Scopus

Orcid

Strengths for the Award:

  1. High-Impact Publications in Prestigious Journals
    Dr. Orlandi has published in top-tier, peer-reviewed journals, including Science, Nature Communications, PNAS, Journal of Physiology, and Molecular Pharmacology. This reflects the scientific rigor, innovation, and broad relevance of his work.

  2. Research Innovation in GPCR Biology
    His research into orphan G protein-coupled receptors (GPCRs) has led to the development of new experimental assays (e.g., GzESTY) and has provided significant insights into immune and neurological signaling mechanisms. These contributions are not only fundamental but also highly translational, aligning with drug discovery and therapeutic interventions.

  3. Strong Interdisciplinary and Collaborative Profile
    Dr. Orlandi’s collaborations with diverse teams across pharmacology, structural biology, and immunology underscore his interdisciplinary approach. His name appears alongside experts from multiple institutions, showing leadership in team science.

  4. Recognition for Scientific Communication
    His awards for Best Talk at Scripps Research Fest (2016, 2018) and selection for a Gordon Research Seminar oral presentation affirm his strength in communicating complex science effectively—an essential trait for broader impact.

  5. Mentorship and Leadership
    As an Associate Professor at the University of Rochester, Dr. Orlandi plays an active role in training the next generation of biomedical researchers, contributing to capacity building in academia.

Areas for Improvement:

  1. Limited Mention of Funding Sources or Grant Leadership
    While his publication record is excellent, there’s no clear listing of major research grants or principal investigator (PI) roles, which are critical markers for research independence and sustainability.

  2. More Visible Clinical or Translational Output
    While his work is biologically impactful, the clinical translation or patenting aspect could be made more visible to demonstrate tangible applications beyond academic impact.

  3. Leadership in International Consortia or Editorial Boards
    Additional involvement in editorial boards, scientific committees, or research policy advisory roles would further bolster his profile as a leader in his field.

Education:

Dr. Orlandi earned his Ph.D. in Molecular Genetics from the University of Brescia, Italy (2005–2009), where he conducted foundational research into genetic signaling mechanisms. Prior to that, he completed a Master of Science in Pharmaceutical Biotechnology at the University of Milan (1998–2004), equipping him with a robust interdisciplinary foundation in drug development, pharmacodynamics, and molecular biology. His academic path reflects a strong European biomedical training system, with emphasis on translational pharmacology and therapeutic innovation. The combination of pharmaceutical science and genetic research uniquely positions Dr. Orlandi to explore receptor biology with a precision medicine lens. His training was further strengthened by postdoctoral research in elite institutions, where he deepened his specialization in orphan GPCR signaling. This education forms the backbone of his research productivity and ability to mentor the next generation of molecular pharmacologists.

Experience:

Dr. Cesare Orlandi currently serves as Associate Professor in the Department of Pharmacology and Physiology at the University of Rochester. He has established himself as a leading voice in the GPCR research community, especially in understanding orphan receptors and their roles in neuronal and immune systems. Prior to this, he held postdoctoral and research positions where he collaborated with global leaders in receptor signaling and neurobiology. His lab combines pharmacological, molecular, and computational approaches to tackle fundamental questions about receptor activity, bias, and downstream signaling. With over a decade of hands-on research experience and extensive publication output, Dr. Orlandi has trained graduate students and postdocs who have progressed into independent academic and industry positions. His multidisciplinary experience spans receptor pharmacology, molecular neuroscience, and drug discovery, making him a cornerstone in collaborative biomedical research projects at the University of Rochester and beyond.

Awards and Honors:

Dr. Orlandi’s scientific excellence has been recognized with several prestigious honors. Notably, he received the Best Talk Award at the Scripps Research Fest in both 2016 and 2018, underscoring his ability to clearly and impactfully communicate complex scientific findings. In 2016, his work was also selected for an oral presentation at the highly competitive Gordon Research Seminar on Phosphorylation and G-Protein Mediated Signaling, affirming the novelty and relevance of his contributions to the receptor signaling field. These awards highlight not only the depth of his scientific insights but also his excellence in mentorship, collaboration, and thought leadership. They place him among a select group of researchers with both technical and communicative brilliance, a critical trait for academic and translational science leadership. These recognitions, combined with high-impact publications, position Dr. Orlandi as a deserving candidate for the Best Researcher Award.

Research Focus:

Dr. Orlandi’s research revolves around orphan G protein-coupled receptors (GPCRs)—a class of proteins that are vital drug targets but remain largely unexplored. His lab develops novel assays (like GzESTY) for GPCR deorphanization, helping decode their physiological roles in the brain and immune system. He also explores signaling bias, investigating how different ligands induce distinct signaling cascades through the same receptor. His recent work uncovered pivotal roles for orphan GPCRs in macrophage immune function and neuronal communication, highlighting their therapeutic potential. Collaborating across pharmacology, neuroscience, and structural biology, he integrates in vitro, in vivo, and computational methods. His lab has also contributed to understanding how GPCRs interact with psychoactive cannabinoids and prostaglandins, which has implications for pain, inflammation, and psychiatric disorders. His research is highly translational, aiming to inform next-generation drug discovery in neuropharmacology and immunomodulation.

Publications Top Notes: 

  1. 🧬 Distinct Interactions of Cannabinol and Its Cytochrome P450-Generated Metabolites with Receptors and Sensory Neurons – Journal of Medicinal Chemistry, 2025

  2. 🧪 Pancreatic Exocrine Signaling and Function Require Gαq Activation – The Journal of Physiology, 2025

  3. 🧫 GzESTY: An Optimized Cell-Based Assay for GPCR Deorphanization – Nature Communications, 2025

  4. 🧉 Orphan GPCR GPRC5B Controls Macrophage Function via Prostaglandin E2 Signaling – Nature Communications, 2025

  5. 🧠 Gα Protein Signaling Bias at the 5-HT1A Receptor – Molecular Pharmacology, 2023

  6. 🧠 Spatial Profile of Orphan GPCR GPRC5B Expression in Mouse Brain – Frontiers in Neuroscience, 2022

  7. 🔍 In Vitro Profiling of Orphan GPCR Constitutive Activity – British Journal of Pharmacology, 2021

  8. 🧩 Cell-Adhesion Molecules Regulate Cone Photoreceptor Synaptic Wiring – PNAS, 2020

  9. 🎮 NF1-cAMP Signaling Links Striatal Neurons to Reward and Motor Control – PLOS Biology, 2019

  10. 🚫 Genetic Behavioral Screen Identifies an Orphan Anti-Opioid System – Science, 2019

Conclusion:

Dr. Cesare Orlandi stands out as an exceptional researcher whose work has advanced the frontiers of molecular pharmacology, especially in the complex field of orphan GPCRs. His innovative methodologies, strong publication track record, and interdisciplinary collaborations make a compelling case for recognition through the Best Researcher Award. While there is room to further highlight his grant leadership and translational reach, his scientific output and leadership are already at a level that merits this award.